Medications

First mutation-targeted bladder cancer drug may be under-used

The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a study from researchers at the Perelman School of Medicine at ...

page 4 from 24